BioProject ID: PRJNA780081
https://www.ncbi.nlm.nih.gov/bioproject/?term=PRJNA780081 
| Attribute | Value |
|---|---|
| SRA Study ID | SRP345979 |
| Disease(s) | COVID-19 → COVID-19 Moderate COVID-19 → COVID-19 Severe COVID-19 → COVID-19 Critical |
| Isolation Source | Nasopharyngeal Swab; Sputum |
| Biome | Lower Respiratory Tract; Upper Respiratory Tract |
| Assay Type | Amplicon-16S |
| Instrument | Illumina MiSeq |
| Library Layout | PAIRED |
| Year | 2021 |
| Processed Runs | 69 |
| Variable Region | V3-V4 |
| PMID | 35838111 |
| Country | China |
Analyses
| Taxonomic profile | |
|---|---|
| Discriminant analysis | |
| Multivariate association analysis | |
| Microbial co-occurrence analysis |
Download
| Biom file |
|---|
Summary of runs
Total number of processed runs found in the database for this BioProject ID = 69
| Go to Page: |
Page 1 / 1 |
| Run ID | BioProject ID | Disease | Disease Sub-group | Biome | Instrument | Assay Type | Library Layout | Processed Reads (%) | Country | Year |
|---|---|---|---|---|---|---|---|---|---|---|
| SRR16939683 | PRJNA780081 | COVID-19 | COVID-19 Severe | Upper Respiratory Tract | Illumina MiSeq | Amplicon-16S | PAIRED | 98 | China | 2021 |
| SRR16939684 | PRJNA780081 | COVID-19 | COVID-19 Moderate | Upper Respiratory Tract | Illumina MiSeq | Amplicon-16S | PAIRED | 99 | China | 2021 |
| SRR16939685 | PRJNA780081 | COVID-19 | COVID-19 Critical | Lower Respiratory Tract | Illumina MiSeq | Amplicon-16S | PAIRED | 79 | China | 2021 |
| SRR16939686 | PRJNA780081 | COVID-19 | COVID-19 Moderate | Upper Respiratory Tract | Illumina MiSeq | Amplicon-16S | PAIRED | 96 | China | 2021 |
| SRR16939687 | PRJNA780081 | COVID-19 | COVID-19 Moderate | Upper Respiratory Tract | Illumina MiSeq | Amplicon-16S | PAIRED | 98 | China | 2021 |
| SRR16939688 | PRJNA780081 | COVID-19 | COVID-19 Moderate | Upper Respiratory Tract | Illumina MiSeq | Amplicon-16S | PAIRED | 78 | China | 2021 |
| SRR16939689 | PRJNA780081 | COVID-19 | COVID-19 Moderate | Upper Respiratory Tract | Illumina MiSeq | Amplicon-16S | PAIRED | 96 | China | 2021 |
| SRR16939690 | PRJNA780081 | COVID-19 | COVID-19 Severe | Upper Respiratory Tract | Illumina MiSeq | Amplicon-16S | PAIRED | 98 | China | 2021 |
| SRR16939691 | PRJNA780081 | COVID-19 | COVID-19 Severe | Upper Respiratory Tract | Illumina MiSeq | Amplicon-16S | PAIRED | 95 | China | 2021 |
| SRR16939692 | PRJNA780081 | COVID-19 | COVID-19 Moderate | Upper Respiratory Tract | Illumina MiSeq | Amplicon-16S | PAIRED | 98 | China | 2021 |
| SRR16939693 | PRJNA780081 | COVID-19 | COVID-19 Moderate | Upper Respiratory Tract | Illumina MiSeq | Amplicon-16S | PAIRED | 90 | China | 2021 |
| SRR16939694 | PRJNA780081 | COVID-19 | COVID-19 Moderate | Upper Respiratory Tract | Illumina MiSeq | Amplicon-16S | PAIRED | 95 | China | 2021 |
| SRR16939695 | PRJNA780081 | COVID-19 | COVID-19 Severe | Upper Respiratory Tract | Illumina MiSeq | Amplicon-16S | PAIRED | 99 | China | 2021 |
| SRR16939696 | PRJNA780081 | COVID-19 | COVID-19 Severe | Upper Respiratory Tract | Illumina MiSeq | Amplicon-16S | PAIRED | 93 | China | 2021 |
| SRR16939697 | PRJNA780081 | COVID-19 | COVID-19 Moderate | Upper Respiratory Tract | Illumina MiSeq | Amplicon-16S | PAIRED | 94 | China | 2021 |
| SRR16939698 | PRJNA780081 | COVID-19 | COVID-19 Severe | Upper Respiratory Tract | Illumina MiSeq | Amplicon-16S | PAIRED | 91 | China | 2021 |
| SRR16939699 | PRJNA780081 | COVID-19 | COVID-19 Severe | Upper Respiratory Tract | Illumina MiSeq | Amplicon-16S | PAIRED | 82 | China | 2021 |
| SRR16939700 | PRJNA780081 | COVID-19 | COVID-19 Moderate | Upper Respiratory Tract | Illumina MiSeq | Amplicon-16S | PAIRED | 93 | China | 2021 |
| SRR16939701 | PRJNA780081 | COVID-19 | COVID-19 Moderate | Upper Respiratory Tract | Illumina MiSeq | Amplicon-16S | PAIRED | 83 | China | 2021 |
| SRR16939702 | PRJNA780081 | COVID-19 | COVID-19 Severe | Upper Respiratory Tract | Illumina MiSeq | Amplicon-16S | PAIRED | 87 | China | 2021 |
| SRR16939703 | PRJNA780081 | COVID-19 | COVID-19 Severe | Upper Respiratory Tract | Illumina MiSeq | Amplicon-16S | PAIRED | 78 | China | 2021 |
| SRR16939704 | PRJNA780081 | COVID-19 | COVID-19 Severe | Upper Respiratory Tract | Illumina MiSeq | Amplicon-16S | PAIRED | 94 | China | 2021 |
| SRR16939705 | PRJNA780081 | COVID-19 | COVID-19 Moderate | Upper Respiratory Tract | Illumina MiSeq | Amplicon-16S | PAIRED | 93 | China | 2021 |
| SRR16939706 | PRJNA780081 | COVID-19 | COVID-19 Moderate | Upper Respiratory Tract | Illumina MiSeq | Amplicon-16S | PAIRED | 89 | China | 2021 |
| SRR16939707 | PRJNA780081 | COVID-19 | COVID-19 Moderate | Upper Respiratory Tract | Illumina MiSeq | Amplicon-16S | PAIRED | 86 | China | 2021 |
| SRR16939708 | PRJNA780081 | COVID-19 | COVID-19 Moderate | Upper Respiratory Tract | Illumina MiSeq | Amplicon-16S | PAIRED | 79 | China | 2021 |
| SRR16939709 | PRJNA780081 | COVID-19 | COVID-19 Moderate | Upper Respiratory Tract | Illumina MiSeq | Amplicon-16S | PAIRED | 80 | China | 2021 |
| SRR16939710 | PRJNA780081 | COVID-19 | COVID-19 Severe | Upper Respiratory Tract | Illumina MiSeq | Amplicon-16S | PAIRED | 82 | China | 2021 |
| SRR16939711 | PRJNA780081 | COVID-19 | COVID-19 Critical | Upper Respiratory Tract | Illumina MiSeq | Amplicon-16S | PAIRED | 92 | China | 2021 |
| SRR16939712 | PRJNA780081 | COVID-19 | COVID-19 Severe | Upper Respiratory Tract | Illumina MiSeq | Amplicon-16S | PAIRED | 93 | China | 2021 |
| SRR16939713 | PRJNA780081 | COVID-19 | COVID-19 Moderate | Upper Respiratory Tract | Illumina MiSeq | Amplicon-16S | PAIRED | 93 | China | 2021 |
| SRR16939714 | PRJNA780081 | COVID-19 | COVID-19 Severe | Upper Respiratory Tract | Illumina MiSeq | Amplicon-16S | PAIRED | 90 | China | 2021 |
| SRR16939715 | PRJNA780081 | COVID-19 | COVID-19 Moderate | Upper Respiratory Tract | Illumina MiSeq | Amplicon-16S | PAIRED | 88 | China | 2021 |
| SRR16939716 | PRJNA780081 | COVID-19 | COVID-19 Moderate | Upper Respiratory Tract | Illumina MiSeq | Amplicon-16S | PAIRED | 92 | China | 2021 |
| SRR16939717 | PRJNA780081 | COVID-19 | COVID-19 Moderate | Upper Respiratory Tract | Illumina MiSeq | Amplicon-16S | PAIRED | 93 | China | 2021 |
| SRR16939718 | PRJNA780081 | COVID-19 | COVID-19 Severe | Upper Respiratory Tract | Illumina MiSeq | Amplicon-16S | PAIRED | 96 | China | 2021 |
| SRR16939719 | PRJNA780081 | COVID-19 | COVID-19 Severe | Upper Respiratory Tract | Illumina MiSeq | Amplicon-16S | PAIRED | 96 | China | 2021 |
| SRR16939720 | PRJNA780081 | COVID-19 | COVID-19 Moderate | Upper Respiratory Tract | Illumina MiSeq | Amplicon-16S | PAIRED | 74 | China | 2021 |
| SRR16939721 | PRJNA780081 | COVID-19 | COVID-19 Severe | Upper Respiratory Tract | Illumina MiSeq | Amplicon-16S | PAIRED | 87 | China | 2021 |
| SRR16939722 | PRJNA780081 | COVID-19 | COVID-19 Severe | Upper Respiratory Tract | Illumina MiSeq | Amplicon-16S | PAIRED | 98 | China | 2021 |
| SRR16939723 | PRJNA780081 | COVID-19 | COVID-19 Moderate | Lower Respiratory Tract | Illumina MiSeq | Amplicon-16S | PAIRED | 80 | China | 2021 |
| SRR16939724 | PRJNA780081 | COVID-19 | COVID-19 Moderate | Upper Respiratory Tract | Illumina MiSeq | Amplicon-16S | PAIRED | 97 | China | 2021 |
| SRR16939725 | PRJNA780081 | COVID-19 | COVID-19 Moderate | Upper Respiratory Tract | Illumina MiSeq | Amplicon-16S | PAIRED | 88 | China | 2021 |
| SRR16939726 | PRJNA780081 | COVID-19 | COVID-19 Moderate | Upper Respiratory Tract | Illumina MiSeq | Amplicon-16S | PAIRED | 87 | China | 2021 |
| SRR16939727 | PRJNA780081 | COVID-19 | COVID-19 Moderate | Upper Respiratory Tract | Illumina MiSeq | Amplicon-16S | PAIRED | 83 | China | 2021 |
| SRR16939728 | PRJNA780081 | COVID-19 | COVID-19 Moderate | Upper Respiratory Tract | Illumina MiSeq | Amplicon-16S | PAIRED | 82 | China | 2021 |
| SRR16939729 | PRJNA780081 | COVID-19 | COVID-19 Moderate | Upper Respiratory Tract | Illumina MiSeq | Amplicon-16S | PAIRED | 92 | China | 2021 |
| SRR16939730 | PRJNA780081 | COVID-19 | COVID-19 Moderate | Upper Respiratory Tract | Illumina MiSeq | Amplicon-16S | PAIRED | 93 | China | 2021 |
| SRR16939731 | PRJNA780081 | COVID-19 | COVID-19 Critical | Upper Respiratory Tract | Illumina MiSeq | Amplicon-16S | PAIRED | 89 | China | 2021 |
| SRR16939732 | PRJNA780081 | COVID-19 | COVID-19 Moderate | Upper Respiratory Tract | Illumina MiSeq | Amplicon-16S | PAIRED | 89 | China | 2021 |
| SRR16939733 | PRJNA780081 | COVID-19 | COVID-19 Severe | Upper Respiratory Tract | Illumina MiSeq | Amplicon-16S | PAIRED | 89 | China | 2021 |
| SRR16939734 | PRJNA780081 | COVID-19 | COVID-19 Moderate | Lower Respiratory Tract | Illumina MiSeq | Amplicon-16S | PAIRED | 92 | China | 2021 |
| SRR16939735 | PRJNA780081 | COVID-19 | COVID-19 Moderate | Lower Respiratory Tract | Illumina MiSeq | Amplicon-16S | PAIRED | 95 | China | 2021 |
| SRR16939736 | PRJNA780081 | COVID-19 | COVID-19 Moderate | Upper Respiratory Tract | Illumina MiSeq | Amplicon-16S | PAIRED | 88 | China | 2021 |
| SRR16939737 | PRJNA780081 | COVID-19 | COVID-19 Severe | Upper Respiratory Tract | Illumina MiSeq | Amplicon-16S | PAIRED | 89 | China | 2021 |
| SRR16939738 | PRJNA780081 | COVID-19 | COVID-19 Moderate | Upper Respiratory Tract | Illumina MiSeq | Amplicon-16S | PAIRED | 81 | China | 2021 |
| SRR16939739 | PRJNA780081 | COVID-19 | COVID-19 Moderate | Upper Respiratory Tract | Illumina MiSeq | Amplicon-16S | PAIRED | 98 | China | 2021 |
| SRR16939740 | PRJNA780081 | COVID-19 | COVID-19 Moderate | Upper Respiratory Tract | Illumina MiSeq | Amplicon-16S | PAIRED | 86 | China | 2021 |
| SRR16939741 | PRJNA780081 | COVID-19 | COVID-19 Moderate | Upper Respiratory Tract | Illumina MiSeq | Amplicon-16S | PAIRED | 84 | China | 2021 |
| SRR16939742 | PRJNA780081 | COVID-19 | COVID-19 Severe | Upper Respiratory Tract | Illumina MiSeq | Amplicon-16S | PAIRED | 64 | China | 2021 |
| SRR16939743 | PRJNA780081 | COVID-19 | COVID-19 Moderate | Lower Respiratory Tract | Illumina MiSeq | Amplicon-16S | PAIRED | 82 | China | 2021 |
| SRR16939744 | PRJNA780081 | COVID-19 | COVID-19 Moderate | Upper Respiratory Tract | Illumina MiSeq | Amplicon-16S | PAIRED | 90 | China | 2021 |
| SRR16939745 | PRJNA780081 | COVID-19 | COVID-19 Severe | Upper Respiratory Tract | Illumina MiSeq | Amplicon-16S | PAIRED | 90 | China | 2021 |
| SRR16939746 | PRJNA780081 | COVID-19 | COVID-19 Severe | Upper Respiratory Tract | Illumina MiSeq | Amplicon-16S | PAIRED | 94 | China | 2021 |
| SRR16939747 | PRJNA780081 | COVID-19 | COVID-19 Severe | Upper Respiratory Tract | Illumina MiSeq | Amplicon-16S | PAIRED | 95 | China | 2021 |
| SRR16939748 | PRJNA780081 | COVID-19 | COVID-19 Moderate | Upper Respiratory Tract | Illumina MiSeq | Amplicon-16S | PAIRED | 92 | China | 2021 |
| SRR16939749 | PRJNA780081 | COVID-19 | COVID-19 Severe | Upper Respiratory Tract | Illumina MiSeq | Amplicon-16S | PAIRED | 95 | China | 2021 |
| SRR16939750 | PRJNA780081 | COVID-19 | COVID-19 Severe | Upper Respiratory Tract | Illumina MiSeq | Amplicon-16S | PAIRED | 93 | China | 2021 |
| SRR16939751 | PRJNA780081 | COVID-19 | COVID-19 Moderate | Upper Respiratory Tract | Illumina MiSeq | Amplicon-16S | PAIRED | 90 | China | 2021 |
| Go to Page: |
Page 1 / 1 |
© 2025 Bose Institute. All rights reserved. For queries, please contact Dr. Sudipto Saha (ssaha4@jcbose.ac.in, ssaha4@gmail.com).